
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Sushil Kumar, Ajeya Nandi, Snahlata Singh, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Sushil Kumar, Ajeya Nandi, Snahlata Singh, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Showing 26-50 of 55 citing articles:
Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 3
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 3
The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer
Nina Jiang, Ye Hu, Meiling Wang, et al.
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 291-309
Open Access | Times Cited: 14
Nina Jiang, Ye Hu, Meiling Wang, et al.
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 291-309
Open Access | Times Cited: 14
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
Amy Tang, Richard Hoefer, Mary L. Guye, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 691-702
Open Access | Times Cited: 12
Amy Tang, Richard Hoefer, Mary L. Guye, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 691-702
Open Access | Times Cited: 12
BMP-4 and BMP-7 Inhibit EMT in a Model of Anterior Subcapsular Cataract in Part by Regulating the Notch Signaling Pathway
Fanying Jiang, Yingyan Qin, Yuanfan Yang, et al.
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 4, pp. 12-12
Open Access | Times Cited: 7
Fanying Jiang, Yingyan Qin, Yuanfan Yang, et al.
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 4, pp. 12-12
Open Access | Times Cited: 7
Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis
Yan Luo, Qingyun Zhu, Shasha Xiang, et al.
Oncogene (2023) Vol. 42, Iss. 44, pp. 3236-3251
Closed Access | Times Cited: 7
Yan Luo, Qingyun Zhu, Shasha Xiang, et al.
Oncogene (2023) Vol. 42, Iss. 44, pp. 3236-3251
Closed Access | Times Cited: 7
Novel small molecule DMAMCL induces differentiation in rhabdomyosarcoma by downregulating of DLL1
Qi Li, Yexi Chen, Yang Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116562-116562
Open Access | Times Cited: 2
Qi Li, Yexi Chen, Yang Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116562-116562
Open Access | Times Cited: 2
Omics and Computational Modeling Approaches for the Effective Treatment of Drug-Resistant Cancer Cells
Hae Deok Jung, Yoo Jin Sung, Hyun Uk Kim
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
Hae Deok Jung, Yoo Jin Sung, Hyun Uk Kim
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
Self-Renewal Inhibition in Breast Cancer Stem Cells: Moonlight Role of PEDF in Breast Cancer
Carmen Gil‐Gas, Marta Sánchez‐Díez, Paloma Honrubia‐Gómez, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5422-5422
Open Access | Times Cited: 6
Carmen Gil‐Gas, Marta Sánchez‐Díez, Paloma Honrubia‐Gómez, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5422-5422
Open Access | Times Cited: 6
Up‐regulation of TNF‐alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma
Letícia Rodrigues de Castro, Lucas Dias de Oliveira, Thaís Moré Milan, et al.
Journal of Cellular Physiology (2023) Vol. 239, Iss. 2
Closed Access | Times Cited: 6
Letícia Rodrigues de Castro, Lucas Dias de Oliveira, Thaís Moré Milan, et al.
Journal of Cellular Physiology (2023) Vol. 239, Iss. 2
Closed Access | Times Cited: 6
Single-Cell RNA-Sequencing Portraying Functional Diversity and Clinical Implications of IFI6 in Ovarian Cancer
Hongyu Zhao, Zhefeng Li, Yan Gao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Hongyu Zhao, Zhefeng Li, Yan Gao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures
Ji Li, Jiayue Qiu, Junwei Han, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 1976-1976
Open Access | Times Cited: 9
Ji Li, Jiayue Qiu, Junwei Han, et al.
Genes (2022) Vol. 13, Iss. 11, pp. 1976-1976
Open Access | Times Cited: 9
Delta/Notch-like Epidermal Growth Factor-Related Receptor (DNER), a Potential Prognostic Marker of Gastric Cancer Regulates Cell Survival and Cell Cycle Progression
Han Thi Ngoc To, Ji‐Hong Park, Jeong Won Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10077-10077
Open Access | Times Cited: 4
Han Thi Ngoc To, Ji‐Hong Park, Jeong Won Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10077-10077
Open Access | Times Cited: 4
Targeting c-Met in Breast Cancer: From Mechanisms of Chemoresistance to Novel Therapeutic Strategies
Emeka Iweala, Doris Nnenna Amuji, Abimbola Mary Oluwajembola, et al.
Current Research in Pharmacology and Drug Discovery (2024) Vol. 7, pp. 100204-100204
Open Access | Times Cited: 1
Emeka Iweala, Doris Nnenna Amuji, Abimbola Mary Oluwajembola, et al.
Current Research in Pharmacology and Drug Discovery (2024) Vol. 7, pp. 100204-100204
Open Access | Times Cited: 1
Notch Pathway Deactivation Sensitizes Breast Cancer Stem Cells toward Chemotherapy Using NIR Light-Responsive Nanoparticles
Yuwei Liu, Yang Zhou, Yunong Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 17, Iss. 1, pp. 430-444
Closed Access | Times Cited: 1
Yuwei Liu, Yang Zhou, Yunong Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 17, Iss. 1, pp. 430-444
Closed Access | Times Cited: 1
Cytotoxic and anticancer activity of a novel synthesized tet-AuNPs simultaneously activates p53 and inhibits NF-kB signaling in SKBR3 cell line
Muhammad Safdar, Mehmet Özaslan, Yasmeen Junejo, et al.
Toxicology and Environmental Health Sciences (2021) Vol. 14, Iss. 1, pp. 69-76
Closed Access | Times Cited: 9
Muhammad Safdar, Mehmet Özaslan, Yasmeen Junejo, et al.
Toxicology and Environmental Health Sciences (2021) Vol. 14, Iss. 1, pp. 69-76
Closed Access | Times Cited: 9
Prognostic evaluation of pancreatic cancer based on the model of chemo-radiotherapy resistance-related genes
Hui‐Chuan Sun, Weigang Zhang, Yunqian Chu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1525-1545
Open Access | Times Cited: 3
Hui‐Chuan Sun, Weigang Zhang, Yunqian Chu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1525-1545
Open Access | Times Cited: 3
Moonlight role of PEDF in breast cancer: self-renewal inhibition in breast cancer stem cells
Carmen Gil‐Gas, Marta Sánchez‐Díez, Paloma Honrubia‐Gómez, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3
Carmen Gil‐Gas, Marta Sánchez‐Díez, Paloma Honrubia‐Gómez, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 3
Mechanical effects modulate drug resistance in MCF-7-derived organoids: Insights into the wnt/β-catenin pathway
Seyed Ali Karimifard, Ali Salehzadeh‐Yazdi, Reza Taghizadeh-Tabarsi, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 695, pp. 149420-149420
Closed Access | Times Cited: 3
Seyed Ali Karimifard, Ali Salehzadeh‐Yazdi, Reza Taghizadeh-Tabarsi, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 695, pp. 149420-149420
Closed Access | Times Cited: 3
Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer
Gabriela Silva, Joana Sales-Dias, Diogo Casal, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4074-4074
Open Access | Times Cited: 6
Gabriela Silva, Joana Sales-Dias, Diogo Casal, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4074-4074
Open Access | Times Cited: 6
Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs
Fengxia Du, Huiwei Sun, Fang Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Fengxia Du, Huiwei Sun, Fang Sun, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer
Dongmei Li, Limei Chen, Xiaofang Zhang, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 5
Open Access | Times Cited: 4
Dongmei Li, Limei Chen, Xiaofang Zhang, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 5
Open Access | Times Cited: 4
Comprehensive Analysis of Inhibitor of Apoptosis Protein Expression and Prognostic Significance in Non–Small Cell Lung Cancer
Jun Liu, Yi Lu, Wenan Huang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 4
Jun Liu, Yi Lu, Wenan Huang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 4
Construction and Validation of a Newly Prognostic Signature for CRISPR-Cas9-Based Cancer Dependency Map Genes in Breast Cancer
Yan Xin, Sainan You, Yan Chen, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 3
Yan Xin, Sainan You, Yan Chen, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 3
[JAG1 promotes migration, invasion, and adhesion of triple-negative breast cancer cells by promoting angiogenesis].
Jun Liu, Yuye Shi, Mingquan Wu, et al.
PubMed (2022) Vol. 42, Iss. 7, pp. 1100-1108
Closed Access | Times Cited: 3
Jun Liu, Yuye Shi, Mingquan Wu, et al.
PubMed (2022) Vol. 42, Iss. 7, pp. 1100-1108
Closed Access | Times Cited: 3
Transcriptomic analysis of MCF7 breast cancer cells treated with MGBs reveals a profound inhibition of estrogen receptor genes
Hasan Y. Alniss, Maha Saber-Ayad, Wafaa S. Ramadan, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107680-107680
Closed Access
Hasan Y. Alniss, Maha Saber-Ayad, Wafaa S. Ramadan, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107680-107680
Closed Access